Published in Osteoporos Int on September 14, 2007
The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. J Bone Miner Res (2011) 1.70
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int (2009) 1.50
GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates. Osteoporos Int (2011) 1.43
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice. Osteoporos Int (2012) 1.42
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int (2009) 1.39
Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care (2009) 1.31
Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice. Clin Interv Aging (2008) 1.22
Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int (2009) 1.14
Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials (2009) 1.12
The impact of teriparatide adherence and persistence on fracture outcomes. Osteoporos Int (2011) 1.09
Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands. Osteoporos Int (2010) 1.05
The complex relation between bisphosphonate adherence and fracture reduction. J Clin Endocrinol Metab (2010) 0.99
Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan. Osteoporos Int (2012) 0.95
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis. Patient Prefer Adherence (2009) 0.94
Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol (2009) 0.93
Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol (2008) 0.90
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates. Osteoporos Int (2009) 0.87
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates. J Clin Endocrinol Metab (2016) 0.85
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporos Int (2011) 0.84
Adherence to anti-osteoporotic therapies: role and determinants of "spot therapy". Osteoporos Int (2013) 0.83
The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis. J Bone Miner Metab (2010) 0.82
Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study. J Bone Miner Metab (2009) 0.82
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis. Osteoporos Int (2013) 0.80
Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations. Ther Adv Chronic Dis (2010) 0.80
If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy. Ther Clin Risk Manag (2011) 0.80
Analysis of the costs and consequences of adherence to therapy in hip fracture patients. Results of a longitudinal analysis of. Clin Cases Miner Bone Metab (2011) 0.80
Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database. Osteoporos Int (2016) 0.80
Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. J Bone Miner Res (2012) 0.79
Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study. Osteoporos Int (2008) 0.78
Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study. J Bone Miner Metab (2011) 0.76
Once-monthly risedronate for postmenopausal osteoporosis. Int J Womens Health (2010) 0.76
Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial. Osteoporos Int (2015) 0.76
Medication burden of Saudi Arabian women receiving antiresorptive therapy. Int J Womens Health (2012) 0.75
Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents. Eur J Clin Pharmacol (2016) 0.75
Upper gastrointestinal tract transit times of tablet and drinkable solution formulations of alendronate: a bioequivalence and a quantitative, randomized study using video deglutition. Calcif Tissue Int (2012) 0.75
Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States. Osteoporos Int (2016) 0.75
Bone mineral density in residents of care facilities for the aged and effect of pharmacotherapy. Yonago Acta Med (2014) 0.75
Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients. Osteoporos Int (2013) 0.75
Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries. Osteoporos Int (2016) 0.75
Real-world clinical and economic outcomes for daily teriparatide patients in Japan. J Bone Miner Metab (2015) 0.75
Risk factors for fracture among current, persistent users of bisphosphonates. Osteoporos Int (2014) 0.75
Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09
Osteoporosis prevention, diagnosis, and therapy. JAMA (2001) 12.60
Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med (2004) 8.86
Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA (2002) 8.30
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc (2006) 5.32
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int (2004) 2.88
Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone (2005) 2.66
Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin (2005) 2.57
Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev (2002) 2.49
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc (2005) 2.07
Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas (2004) 2.03
Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med (2002) 1.71
Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int (2006) 1.61
Use of beta-blockers and risk of fractures. JAMA (2004) 1.58
Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol (2003) 1.57
Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int (2006) 1.56
Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.44
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO). Curr Med Res Opin (2005) 1.33
Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Clin Ther (2006) 1.32
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis. Curr Med Res Opin (2007) 1.08
Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. Curr Med Res Opin (2006) 1.08
Utility of medical and drug history in fracture risk prediction among men and women. Bone (2002) 1.06
Bisphosphonates in osteoporosis: recent clinical experience. Expert Opin Pharmacother (2000) 0.88
Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity. Rev Gastroenterol Disord (2002) 0.86
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot Microbiol (2002) 2.75
Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science (2010) 2.58
Willingness to perform euthanasia. A survey of physician attitudes. Arch Intern Med (1994) 2.28
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol (2001) 2.12
Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer (2003) 1.70
Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax (2008) 1.68
N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J (2003) 1.57
Massage therapy and therapeutic touch in children: state of the science. Altern Ther Health Med (2000) 1.55
Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54
Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol (2012) 1.50
Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections. J Antimicrob Chemother (1994) 1.48
Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans. Infect Immun (2000) 1.46
Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ (2002) 1.43
Surgical wound infections. A 5-year prospective study of 20,193 wounds at the Minneapolis VA Medical Center. Ann Surg (1984) 1.40
Treatment of ABO hemolytic disease with synthetic blood group trisaccharides. Vox Sang (1994) 1.40
The MBEC Assay System: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol (2001) 1.22
Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene (2006) 1.21
Evaluation of a standard breast tangent technique: a dose-volume analysis of tangential irradiation using three-dimensional tools. Int J Radiat Oncol Biol Phys (2000) 1.20
Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun (2001) 1.18
Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis. Curr Med Res Opin (2008) 1.14
Long term persistence with statin treatment in daily medical practice. Heart (2004) 1.13
Precision measurement of the weak mixing angle in Møller scattering. Phys Rev Lett (2005) 1.13
Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology (1996) 1.12
Explosive outbursts in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.10
Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. Curr Med Res Opin (2006) 1.08
Persistence with inhaled corticosteroid therapy in daily practice. Respir Med (2004) 1.08
Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study. J Womens Health Gend Based Med (2000) 1.06
Molecular and phylogenetic analysis of Cryptosporidium muris from various hosts. Parasitology (2000) 1.06
Organization of the 5S rRNA genes in the soybean Glycine max (L.) Merrill and conservation of the 5S rDNA repeat structure in higher plants. Genome (1990) 1.04
Salmon calcitonin: a review of current and future therapeutic indications. Osteoporos Int (2007) 1.02
Terminal myeloid gene expression and differentiation requires the transcription factor PU.1. Curr Top Microbiol Immunol (1996) 1.01
Cardiac troponin I measurement with the ACCESS immunoassay system: analytical and clinical performance characteristics. Clin Chem (1998) 0.99
History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. J Am Coll Cardiol (2001) 0.99
Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection. J Virol (2001) 0.98
Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Urol (2003) 0.97
Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol (2006) 0.97
Hereditary defects of the conotruncal septum in Keeshond dogs: pathologic and genetic studies. Am J Cardiol (1974) 0.96
Hyperphosphorylation of N-60, a protein structurally and immunologically related to nucleolin after tumour-promoter treatment. EMBO J (1988) 0.96
Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin? Eur J Cancer (2007) 0.94
The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis (2008) 0.94
Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol (2008) 0.94
Prostate carcinoma metastatic to the penis: magnetic resonance imaging and brachytherapy. J Urol (1996) 0.93
Effect of enamel bleaching on the bonding strength of orthodontic brackets. Am J Orthod Dentofacial Orthop (1993) 0.93
Adenosquamous carcinoma of the pancreas. Int J Pancreatol (1999) 0.91
Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice. Diabet Med (2004) 0.91
The delta and delta ' subunits of the DNA polymerase III holoenzyme are essential for initiation complex formation and processive elongation. J Biol Chem (2001) 0.90
[Plea for the retention of the Dutch National Medical Registration (LMR) to provide reliable information regarding public health and healthcare]. Ned Tijdschr Geneeskd (2006) 0.89
Defining a role for endoscopic ultrasound in staging periampullary tumors. Am J Surg (2000) 0.89
Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study. Pharmacoepidemiol Drug Saf (2006) 0.89
Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. J Thromb Haemost (2007) 0.89
Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: the WISE study. Psychosom Med (2001) 0.88
Factors associated with switching from oral hypoglycaemic agents to insulin therapy. Neth J Med (2002) 0.87
An ecological study of infected urinary stone genesis in an animal model. Br J Urol (1987) 0.87
Expression of tumor necrosis factor alpha and granulocyte-macrophage colony-stimulating factor by bovine endothelial cells in vitro. Clin Infect Dis (1997) 0.86
Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor. Am J Physiol Gastrointest Liver Physiol (2000) 0.85
Influences of a relaxation intervention on perceived stress and power spectral analysis of heart rate variability. Prog Cardiovasc Nurs (2001) 0.84
Antibiotic pharmacokinetics in the inflamed prostate. J Urol (1995) 0.84
Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cancer Epidemiol (2009) 0.83
Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. J Clin Endocrinol Metab (2009) 0.82
Giardiasis in pinnipeds from eastern Canada. J Wildl Dis (1999) 0.82
Flounder antifreeze peptides increase the efficacy of cryosurgery. Cryobiology (2001) 0.82
Surgical wound infections at the Minneapolis Veterans Administration Medical Center. Minn Med (1982) 0.82
Alterations of cardiovascular control in high spinal myelomalacia. Arch Phys Med Rehabil (1967) 0.81
Utilisation pattern of fentanyl transdermal system in The Netherlands. Pharmacoepidemiol Drug Saf (2005) 0.81
The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med (2000) 0.81
Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. J Am Diet Assoc (1995) 0.80
Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators. Am J Cardiol (2000) 0.80
The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. QJM (2008) 0.80
The effects of phenobarbital and diphenylhydantoin on liver function and morphology. J Pediatr (1980) 0.79
Observation of parity nonconservation in møller scattering. Phys Rev Lett (2004) 0.79
[Rising costs of drugs in hospitals in the period 1996-2000 and over the next few years]. Ned Tijdschr Geneeskd (2002) 0.79
Cytotoxic conjugates containing translational inhibitory proteins. Annu Rev Pharmacol Toxicol (1992) 0.79
Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients. Eur Heart J (2002) 0.79
Interrelations between fatty acid oxidation and the control of gluconeogenesis in perfused rat liver. Adv Enzyme Regul (1968) 0.79
Does the choice of anesthetic technique affect the recovery of bowel function after radical prostatectomy? Urology (1998) 0.78
Obsessive-compulsive symptomatology in children with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry (1987) 0.78
Social support and social adjustment: implications for mental health professionals. Community Ment Health J (1979) 0.78
Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. Eur Urol (2002) 0.77
Hemoglobin North Shore: a variant hemoglobin associated with the phenotype of beta-thalassemia. Blood (1983) 0.77
Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of enterococci causing peritonitis. Perit Dial Int (2007) 0.77
Very low prevalence of bovine immunodeficiency virus infection in western Canadian cattle. Can J Vet Res (2001) 0.77
The association between antihypertensive drugs and glioma. Br J Cancer (2006) 0.77
Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study. Pharm World Sci (2005) 0.76
Interaction of IgG and IgM anti-A with synthetic oligosaccharides. Transplant Proc (1987) 0.76
The experience of therapeutic touch for novice recipients. J Holist Nurs (1997) 0.76
Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhage. J Thromb Haemost (2011) 0.76
Understanding addiction. J Obstet Gynecol Neonatal Nurs (1998) 0.75
Motion artifact simulating aortic dissection. AJR Am J Roentgenol (1993) 0.75
Beta-glucuronidase activity, and levels of protein and protein fractions in serum and cerebrospinal fluid of dogs with distemper associated demyelinating encephalopathy. Acta Neuropathol (1973) 0.75
Nutritional status of Chippewa Head Start children in Wisconsin. Am J Public Health (1977) 0.75
[Prevalence of diabetes mellitus in the Netherlands more than doubled in the period 1999-2014]. Ned Tijdschr Geneeskd (2017) 0.75
Social influence on decision-making. J Nurs Educ (1968) 0.75
Therapeutic touch and post-Hurricane Hugo stress. J Holist Nurs (1992) 0.75
High touch/high tech. S C Nurse (1993) 0.75
Life satisfaction, life review, and near-death experiences in the elderly. J Holist Nurs (1993) 0.75